Sound waves vs. seizures: new ultrasound treatment for epilepsy
NCT ID NCT07249190
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether focused ultrasound waves can safely reduce seizures in 20 adults with drug-resistant epilepsy. The procedure uses MRI guidance to precisely target a small brain area involved in seizure spread. Researchers will monitor side effects and seizure frequency for two years to see if this non-surgical approach works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MR-guided focused ultrasound (procedure)
What this could lead to
If successful, this could offer a non-invasive option to reduce seizures in people with drug-resistant epilepsy, potentially improving quality of life.
What could go wrong
This is a very early Phase 1 trial with only 20 people. The procedure may not reduce seizures, and risks include side effects from brain ablation, MRI claustrophobia, or radiation exposure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY (TREATMENT REFRACTORY) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••